Proofreading Ensures
Functional Proteins
|
RNA polymerase II (pol II) is responsible for the production of messenger
RNA, which serve as templates for the synthesis of all proteins, including
key enzymes, scaffold proteins, hormones, etc. Because a low error rate
during transcription is critical, pol II is very selective in nucleotide
triphosphate (NTP) loading and incorporation; it also uses proofreading
to improve overall transcription accuracy. During RNA transcription, pol
II occasionally reverse-translocates—or backtracks—along the
growing strand of RNA, correcting any mistakes that have been made. The
newly created (3′) end of the RNA strand is extruded from the active
center of pol II, allowing the RNA transcript to be checked and repaired.
Pol II assumes one of three major states during the transcription elongation
phase. The pre-translocation state occurs when a newly added nucleotide
still occupies pol II's nucleotide addition site. In the post-translocation
state, the nucleotide addition site is vacant, available for the
next NTP. The backtracked state occurs during reverse-translocation
and is dominant during nucleotide misincorporation or when pol II runs into
DNA damage or other impediments.
The structures of the pre-translocation and post-translocation states were
solved in 2001 and 2004. In this research, the structure of the pol II complex
in the backtracked state was solved at ALS Beamlines 5.0.2 and 8.2.2.
Using a hybrid containing one mismatched residue at the 3′ end of
the RNA, researchers found the last correctly matched residue positioned
within the nucleotide addition site, and the mismatched residue
located at a novel site called 'P' for proofreading. The mismatched
residue's interaction with pol II distorts the RNA–DNA helix,
making forward transcription difficult. The enzyme's equilibrium
shifts toward the backtracked state.

Left: Structure of pol II elongation complex
in the backtracked state of a complex with one mismatched residue
at the 3′ end of the RNA. RNA and DNA are red and cyan.
Ribonucleotides at +1 and +2 positions in the RNA are yellow
and blue. Parts of the bridge helix and trigger loop are green
and cyan. The bridge helix guides the template DNA strand into
the active center and positions the DNA–RNA hybrid relative
to the catalytic site. Right: Backtracked RNA is kinked toward
the bridge helix and differs from the canonical form of RNA.
Backbones of one-base–mismatch backtracked RNA (red, yellow,
and blue) and canonical form RNA (gray) are superimposed. The
superimposed two-base–mismatch
structure is shown in magenta.
One of two important conclusions of this research is that pol II backtracked
by one residue is stable, even reversible. In the course of backtracking,
pol II stalls at this position, supporting the idea that there
is equilibrium between forward and backward motion during transcription.
This confirms that backtracking one residue is preferable to going back
several residues, which can lead to arrest (irreversible backtracking).
Recovery from arrest is only possible by cleaving the transcript and excising
the misincorporated nucleotide(s).
The second conclusion is that the distorted helix that causes pol II to
backtrack one residue allows for cleavage by elongation factor
IIS (TFIIS) and for intrinsic cleavage (cleavage without TFIIS). However,
the one-residue backtracked state is more readily cleaved in the presence
of TFIIS, which rescues the complex from arrest and releases a dinucleotide.
This strengthens the theory that cleavage occurs in the pol II active site,
and that such cleavage is important for removal of misincorporated nucleotides.
In summary, pol II's forward movement along a DNA template is driven
by NTP loading during normal transcription elongation—unless a mismatch
causes the RNA–DNA helix to distort, shifting the polymerase into
the backtracked state. If it remains in the backtracked state for
too long, cleavage ensues. The one-residue backtracked state is
a key contributor to pol II's proofreading ability, and plays an
important role in increasing the fidelity of RNA polymerase
Research conducted by D. Wang, D.A. Bushnell, X. Huang, K.D. Westover,
M. Levitt, and R.D. Kornberg (Stanford University School of Medicine).
Research funding: National Institutes of Health. Operation of the ALS is
supported by the U.S. Department of Energy, Office of Basic Energy Sciences.
Publication about this research: D. Wang, D.A. Bushnell, X. Huang,
K.D. Westover, M. Levitt, and R.D. Kornberg, "Structural
basis of transcription: Backtracked RNA polymerase II at 3.4 angstrom
resolution," Science 324, 5931 (2009). |